The Middle East and Africa infusion (elastomeric) pumps market refers to the industry encompassing the production, distribution, and utilization of elastomeric infusion pumps across the region. These pumps are medical devices designed for controlled and continuous patient drug delivery. Unlike traditional electronic pumps, elastomeric pumps utilize a flexible elastomeric balloon or reservoir that contracts, delivering the medication through a catheter or tubing. As healthcare systems in the Middle East and Africa continue to evolve, the infusion pump market is poised to play a pivotal role in enhancing patient care and treatment outcomes throughout the region.
Access Full Report @ https://www.databridgemarketresearch.com/reports/middle-east-and-africa-infusion-elastomeric-pumps-market
Data Bridge Market Research analyses that the Middle East and Africa Infusion (Elastomeric) Pumps Market, which was USD 86.83 million in 2021, is expected to reach USD 179.47 million by 2029 and is expected to grow at a CAGR of 9.5% in the forecast period of 2022 to 2029. Government initiatives and subsidies in the Middle East and Africa fuel the elastomeric infusion pumps market, promoting accessibility to advanced medical technologies and enhancing healthcare services for effective and continuous patient treatment.
Key Findings of the Study
Increasing surgical procedures is expected to drive the market's growth rate
The surge in surgical procedures in the Middle East and Africa is a pivotal driver for the elastomeric infusion pumps market. As the volume of surgeries rises, the demand for effective post-operative pain management escalates. Elastomeric infusion pumps, known for their efficacy and user-friendly design, are increasingly preferred for their ability to provide controlled and continuous medication delivery. This trend underscores the integral role these pumps play in enhancing patient recovery and contributes significantly to the market's growth in the region.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014-2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Elastomeric Infusion Pumps, Accessories and Consumables), Route of Administration (Subcutaneous, Intravenous (IV), Intramuscular, and Epidural), Application (Antibiotic/Antiviral Therapy, Pain Management, Chemotherapy, Thalassemia Treatment, Diuretics Treatment, Long Term Infusion Treatment, Other Applications), End User (Hospitals, Homecare Settings, Ambulatory Surgical Centers, Academic and Research Institutes, Specialty Clinics, and Others), Distribution Channel (Direct Tender, Retail Sales, Online Sales, and Others)
|
|
Countries Covered
|
South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa
|
|
Market Players Covered
|
B. Braun SE (Germany), Epic Medical (U.S.), ICU Medical, Inc. (U.S.), Werfen (Spain), Nipro (Japan), AVNS (India), Baxter (U.S.) among others
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The Middle East and Africa infusion (elastomeric) pumps market is segmented on the basis of product type, route of administration, application, end user and distribution channel.
- On the basis of product type, the Middle East and Africa infusion (elastomeric) pumps market is segmented into elastomeric infusion pumps, and accessories and consumables
- On the basis of route of administration, the Middle East and Africa infusion (elastomeric) pumps market is segmented into subcutaneous, intravenous (IV), epidural and intramuscular
- On the basis of application, the Middle East and Africa infusion (elastomeric) pumps market is segmented into pain management, antibiotic/antiviral therapy, chemotherapy, thalassemia treatment, diuretics treatment, long term infusion treatment and other applications
- On the basis of end user, the Middle East and Africa infusion (elastomeric) pumps market is segmented into hospitals, homecare settings, ambulatory surgical centers, academic and research institutes, specialty clinics and others
- On the basis of distribution channel, the Middle East and Africa infusion (elastomeric) pumps market is segmented into direct tender, retail sales, online sales and others
Major Players
Data Bridge Market Research recognizes the following companies as the major Middle East and Africa infusion (elastomeric) pumps market players in Middle East and Africa infusion (elastomeric) pumps market are B. Braun SE (Germany), Epic Medical (U.S.), ICU Medical, Inc. (U.S.), Werfen (Spain), Nipro (Japan), AVNS (India), Baxter (U.S.)
Market Developments
- In June 2023, Eitan Medical successfully concluded the sale of its wearable injectors business to LTS, a leading pharmaceutical technology company. This strategic move aligns with Eitan Medical's focus on its core infusion treatment portfolio, emphasizing advanced infusion therapy and drug delivery solutions. The transition enhances both companies' strategic objectives and reinforces Eitan Medical's commitment to its core business
- In February 2023, Mindray launched the BeneFusion i Series and u Series infusion systems, offering high precision and adaptive customization. Designed for versatility in clinical settings such as endoscopy, obstetrics, and emergency departments, these smart pumps enhance medication safety, streamline workflow, and reduce pharmaceutical errors. The advanced features contribute to increased cost-effectiveness across various medical fields
- In August 2022, Baxter International Inc announced FDA clearance for the Novum IQ Syringe Infusion Pump with Dose IQ Safety Software, ensuring precise medication delivery. This growth enhances healthcare accessibility in both emerging and developed nations, strengthening the company's global product and service portfolio, and reinforcing its commitment to advancing patient safety and care
- In March 2022, Shanghai MicroPort Lifesciences Co., Ltd. obtained marketing approval from China's National Medical Products Administration (NMPA) for its innovative AutoEx Chemotherapy Infusion Pump (AutoEx). This signifies a milestone for the company in bringing its independently developed medical device to market, addressing the need for advanced chemotherapy infusion solutions in the healthcare landscape
- In February 2021, Mindray Medical expanded its product portfolio with the launch of the BeneFusion e series-esp, evp, and eds infusion systems. This strategic move aimed to offer advanced and diversified solutions in the medical equipment sector, showcasing Mindray's commitment to innovation and meeting the evolving needs of healthcare professionals and patients
For more detailed information about the Middle East and Africa infusion (elastomeric) pumps market report, click here – https://www.databridgemarketresearch.com/reports/middle-east-and-africa-infusion-elastomeric-pumps-market
